By Bhanvi Satija and Sriparna Roy (Reuters) – Johnson & Johnson and Merck on Monday announced plans to buy cancer therapy developers on the first day of a major U.S. healthcare conference, i[...]
Read moreJanuary 8, 2024
Atlanta Fed’s Bostic says bias remains for policy to stay tight
By Howard Schneider ATLANTA, Georgia (Reuters) – Atlanta Federal Reserve President Raphael Bostic said on Monday that with inflation still above the central bank’s 2% target, his bias is f[...]
Read moreCanada’s anti-money laundering body to leverage AI bets to crack down on bad actors
By Nivedita Balu TORONTO (Reuters) – Canada’s anti-money laundering agency is increasing its reliance on artificial intelligence (AI) to detect suspicious transactions, betting the use of[...]
Read moreExclusive-China regulators lift stock net-selling ban for mutual funds-sources
SHANGHAI/SINGAPORE (Reuters) – China’s securities regulator is allowing mutual fund managers to sell more shares than they buy each day, three sources said, removing a ban introduced late[...]
Read moreWould-be spot bitcoin ETF issuers kick off fee war ahead of approval deadline
By Niket Nishant, Hannah Lang and Suzanne McGee (Reuters) -A raft of investment managers on Monday disclosed the fees they plan to charge for their proposed spot bitcoin exchange-traded funds (ETF), i[...]
Read moreNetflix beats shareholder lawsuit over account-sharing disclosures
(Reuters) – Netflix has defeated a lawsuit filed by shareholders in a federal court in California that accused the streaming entertainment company of hiding the extent to which account-sharing w[...]
Read moreEyes on regional economic reports, Taiwan elections
By Alden Bentley (Reuters) – A look at the day ahead in Asian markets. U.S. payrolls and service sector data won’t offer much inspiration to Asian markets this week, thanks to the ambiguou[...]
Read moreAbercrombie, Lululemon signal strong holiday season after raised quarterly targets
By Granth Vanaik and Juveria Tabassum (Reuters) -Apparel retailers including Lululemon and Abercrombie & Fitch on Monday offered fresh signs of a stronger-than-expected holiday shopping season in[...]
Read moreModerna says it hit its 2023 COVID vaccine sales goal
By Michael Erman and Bhanvi Satija (Reuters) -Moderna on Monday said its 2023 COVID vaccine sales would be around $6.7 billion, coming in above the lower end of its full-year forecast, and reiterated[...]
Read more